Cited by 306Cardiovascular Effects of ExerciseCardiac pacing and defibrillation studiesCardiac electrophysiology and arrhythmias

Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia

Open access
Corrado, Domenico, Calkins, Hugh, Link, Mark S., Leoni, Loira, Favale, Stefano, Bevilacqua, Michela, Basso, Cristina, Ward, Deirdre +12 more·2010·Circulation

Abstract

BACKGROUND: The role of implantable cardioverter-defibrillator (ICD) in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation (VF) or sustained ventricular tachycardia is an unsolved issue. METHODS AND RESULTS: We studied 106 consecutive patients (62 men and 44 women; age, 35.6±18 years) with arrhythmogenic right ventricular cardiomyopathy/dysplasia who received an ICD based on 1 or more arrhythmic risk factors such as syncope, nonsustained ventricular tachycardia, familial sudden death, and inducibility at programmed ventricular stimulation. During follow-up of 58±35 months, 25 patients (24%) had appropriate ICD interventions and 17 (16%) had shocks for life-threatening VF or ventricular flutter. At 48 months, the actual survival rate was 100% compared with the VF/ventricular flutter-free survival rate of 77% (log-rank P=0.01). Syncope significantly predicted any appropriate ICD interventions (hazard ratio, 2.94; 95% confidence interval, 1.83 to 4.67; P=0.013) and shocks for VF/ventricular flutter (hazard ratio, 3.16; 95% confidence interval, 1.39 to 5.63; P=0.005). The positive predictive value of programmed ventricular stimulation was 35% for any appropriate ICD intervention and 20% for shocks for VF/ventricular flutter, with a negative predictive value of 70% and 74%. None of the 27 asymptomatic patients with isolated familial sudden death had appropriate ICD therapy. Twenty patients (19%) had inappropriate ICD interventions, and 18 (17%) had device-related complications. CONCLUSIONS: One fourth of patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior sustained ventricular tachycardia or VF had appropriate ICD interventions. Syncope was an important predictor of life-saving ICD intervention and is an indication for ICD. Prophylactic ICD may not be indicated in asymptomatic patients because of their low arrhythmic risk regardless of familial sudden death and programmed ventricular stimulation findings. Programmed ventricular stimulation had a low predictive accuracy for ICD therapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.109.913871

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A history of syncope in patients with structural heart disease or inheritable arrhythmia syndromes is associated with a two- to four-fold increased risk of death, but this varies between specific conditions.

    “In general, a history of syncope in patients with structural heart disease or inheritable arrhythmia syndromes is associated with a two- to four-fold increased risk of death, 348,350-353 but varies between specific conditions. 354-356”

    From 2018 ESC Guidelines for the diagnosis and management of syncope (2018) · cites this paper as [351]

    Our indexed copy contains a bibliographic record (no section or page of article text), not a passage about syncope or mortality risk. Searches for the two- to four-fold risk and for syncope-related mortality returned only that record, so the claim cannot be checked against the available copy. (LLM, conf=0.70)

    Experimental — accuracy not yet measured
  • Current data suggest that unexplained syncope is a marker of arrhythmic risk in patients with arrhythmogenic right ventricular cardiomyopathy.

    “Although limited and diverse, current data suggest that unexplained syncope is a marker of arrhythmic risk in patients with ARVC. 46,351,362,363”

    From 2018 ESC Guidelines for the diagnosis and management of syncope (2018) · cites this paper as [351]

    The available copy consists of a bibliographic record with no discussion of syncope or arrhythmic risk. Searches for unexplained syncope and ventricular-arrhythmia risk returned only that record, so this copy cannot verify the claim. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Corrado, D., Calkins, H., Link, M. S., Leoni, L., Favale, S., Bevilacqua, M., Basso, C., Ward, D., Boriani, G., Ricci, R., Piccini, J. P., Dalal, D., Santini, M., Buja, G., Iliceto, S., Estes, N. A. M., Wichter, T., McKenna, W. J., Thiene, G., & Marcus, F. I.
Affiliations
  • Tufts Medical Center (US)
  • From the Department of Cardiac, Thoracic, and Vascular Sciences, University of Padua Medical School, Padua, Italy (D.C., L.L., M.B., G.B., S.I.); Department of Cardiology, Johns Hopkins Hospital, Baltimore, Md (H.C., J.P.P., D.D.); Tufts Medical Center, Boston, Mass (M.S.L., N.A.M.E.); Department of Cardiology, University of Bari, Bari, Italy (S.F.); Department of Medical-Diagnostic Sciences and Special Therapies, University of Padua, Padua, Italy (C.B., G.T.); The Heart Hospital, University College...
Venue
Circulation
Published
2010-09-21
Volume
122
Issue
12
Pages
1144-1152
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2000286264
Cited by
306
References
25
Citations by year
2026: 6 · 2025: 5 · 2024: 5 · 2023: 21 · 2022: 12 · 2021: 22 · 2020: 11 · 2019: 22 · 2018: 21 · 2017: 31 · 2016: 21 · 2015: 27 · 2014: 26 · 2013: 19 · 2012: 35
FWCI
16.69
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
  • CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
  • Lenus, The Irish Health Repository (Dr Steevens Hospital Library) (submittedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords
arrhythmogenic right ventricular cardiomyopathy, implantable cardioverter-defibrillator, prophylactic ICD, syncope, programmed ventricular stimulation, ventricular fibrillation, ventricular flutter, sudden cardiac death, arrhythmia risk prediction, inappropriate shocks, device complications, familial sudden death, young adults
MeSH terms
Adolescent, Adult, Female, Follow-Up Studies, Humans, International Cooperation, Male, Middle Aged, Retrospective Studies, Ventricular Fibrillation, Survival Rate, Treatment Outcome, Defibrillators, Implantable, Tachycardia, Ventricular, Arrhythmogenic Right Ventricular Dysplasia, Electrophysiologic Techniques, Cardiac, Kaplan-Meier Estimate, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review